Products

Sleepiz One+
Sleepiz
Cardiology AI
Sleepiz One+ is an FDA-cleared contactless remote patient monitoring device that collects biometric data and records vital signs from a patient's bedside, providing comprehensive respiration and heart rate monitoring for chronic conditions.

See all 1 product →

About Sleepiz

Sleepiz is a Swiss medical technology company that develops AI-based, contactless monitoring devices for sleep and vital parameters. Their flagship product, the Sleepiz One+, is a Class IIa CE-marked medical device (Europe) and has received FDA Class II 510(k) clearance (US) for vital sign monitoring. The device is designed for home use and is simply placed on a bedside table, operating in a non-contact fashion to measure movements originating from heart contractions, breathing patterns, and body motions with medical-grade accuracy. This technology allows for the diagnosis of sleep disorders, such as sleep apnea, and long-term monitoring of chronic diseases, providing physicians with continuous data rather than relying on single, random measurements.

For physicians, Sleepiz offers a convenient and efficient tool for patient-centric disease management. The device facilitates examinations over several nights in the patient’s natural sleep environment, increasing the validity of the data and reducing patient discomfort associated with traditional wired sleep studies. The collected data is securely transmitted to a cloud platform and analyzed by Sleepiz’s team of experts, providing high-quality data analysis and insightful reports that can be discussed with patients. Sleepiz’s solutions are designed to help identify health issues early, support managing chronic conditions, and enable remote patient monitoring (RPM), with the potential for reimbursement using Current Procedural Terminology (CPT) codes in the US. The company also partners with healthcare organizations and researchers to integrate novel sleep and respiratory parameters into clinical trials, offering new data endpoints for a more comprehensive understanding of patients’ conditions.

Focus Areas

sleep monitoring respiratory disease monitoring contactless vital sign monitoring remote patient monitoring AI in healthcare digital health medical devices

Business Intelligence

Key InvestorsZürcher Kantonalbank (ZKB), Venture Kick, Verve Ventures, Hemex AG, EIT Health e.V., Marcaro, Nurture Ventures, Riceberg Ventures, TiE Silicon Valley, AAL Programme
PartnershipsClario, Acconeer, University of Gothenburg's Sleep Medicine Center, Lunge Zurich association, Swiss Terz Foundation, In4Care Happy Aging, Aalborg University
Technologywireless millimeter wave technology, sensor fusion, artificial intelligence, cloud-native
FDA Clearances1 cleared products (estimated)

What Physicians Need to Know

Sleep Apnea Diagnosis
Sleepiz offers a contactless, radar-based device (Sleepiz One+) for the diagnosis of sleep apnea, particularly effective for moderate to severe Obstructive Sleep Apnea (OSA). It provides an alternative to traditional polysomnography (PSG), which can be inconvenient and expensive.
Chronic Respiratory Disease Monitoring
The Sleepiz One+ device is cleared by the FDA for contactless remote patient monitoring (RPM) of respiration and heart rate, assisting in the early detection of deterioration in patients with chronic medical conditions, including chronic respiratory diseases.
Contactless Vital Sign Monitoring
Sleepiz specializes in monitoring heart rate, respiration rate, and body motion without physical contact, using radar technology. The device is placed on a bedside table and measures these vital signs through bedding and clothing.
Remote Patient Monitoring (RPM)
Sleepiz provides a remote patient monitoring service that allows for continuous, at-home capture of sleep and vital-sign metrics, accessible to clinicians via a web interface. The Sleepiz One+ is designed for ease of installation and use by patients.
Clinical Trial Data Collection
Sleepiz partners with healthcare research technology companies to integrate contactless sleep and respiratory measurements into clinical trials, providing novel data endpoints and enabling accurate, comfortable, and natural data collection through unobtrusive radar technology.
AI-Driven Sleep Analytics
At the core of Sleepiz's technology is its AI-driven sleep analytics software, which processes radar signals to derive vital sign statistics and comprehensive sleep parameters, including sleep start/end time, efficiency, awakenings, sleep staging, and Apnea-Hypopnea Index (AHI).
Digital Signal Processing & Sensor Fusion
Sleepiz utilizes digital signal processing to transform raw radar signals into meaningful physiological parameters and employs sensor fusion to enhance data accuracy and insights.
Physician Tip

For physicians, Sleepiz offers a convenient, patient-centric solution for diagnosing sleep apnea and continuously monitoring vital signs in chronic respiratory disease patients from their homes, reducing the need for in-clinic visits and cumbersome wearable devices. The FDA-cleared Sleepiz One+ allows for short- and long-term monitoring, providing enhanced insights into disease progression or remission and enabling timely interventions. The device is easy for patients to set up and use, and physicians can reimburse its use through existing CPT codes for remote patient monitoring. The multi-night, at-home examination increases data validity compared to single, in-clinic measurements, and the contactless nature improves patient comfort and compliance. Sleepiz also provides access to comprehensive data and analytics through a web interface, supporting informed decision-making and potentially opening new areas in sleep medicine.

Sleepiz's technology, including its AI-driven sleep analytics and cloud-based data platform, is designed for integration. It offers SDK/API access for partners to integrate vital sign and sleep metrics into their devices with radar chips. The Sleepiz One+ device is also integrated into remote patient monitoring and clinical study platforms, facilitating comprehensive data collection for healthcare professionals and researchers.

Products by Sleepiz

1 product in the directory

Sleepiz One+
Sleepiz
Cardiology AI
Sleepiz One+ is an FDA-cleared contactless remote patient monitoring device that collects biometric data and records vital signs from a patient's bedside, providing comprehensive respiration and heart rate monitoring for chronic conditions.

What the Web Says

Sleepiz is generally viewed as an innovative company in the healthcare technology space, particularly for its non-contact sleep monitoring solutions. While the product receives praise for its accuracy and ease of use in clinical settings, there's limited public information regarding employer reviews on major platforms like Glassdoor, Capterra, or G2, suggesting it might be a smaller or more niche company without widespread employee feedback readily available.

Overall: Positive

Strengths

  • Non-contact and comfortable sleep monitoring
  • High accuracy in detecting sleep stages and events (e.g., AHI)
  • Suitable for clinical and home use
  • Addresses a need for less intrusive sleep diagnostics
  • Innovative technology with potential for broader applications
  • Positive feedback from healthcare professionals regarding clinical utility

Limitations

  • Limited public reviews on major employer/product platforms (Glassdoor, Capterra, G2)
  • Specific pricing information not readily available
  • Potential for data privacy concerns (though not explicitly mentioned in reviews, common for health tech)
  • May require professional interpretation of data
  • Niche product, not for general consumer use
  • Lack of widespread consumer-level product reviews

Based on reviews from: Sleepiz Official Website (for product information and claims), Healthcare IT review sites (general industry discussions, not specific reviews), Clinical studies and publications referencing Sleepiz technology, Industry news articles and press releases, LinkedIn (for company profile and employee insights)

Last updated: 2026-07-02

Videos

News, demos, and interviews about Sleepiz.

Loading videos...

Videos load interactively. If none appear, search YouTube for Sleepiz →

View all on YouTube

Press & Coverage

Sleep Review
FDA Clears Bedside Device for Contactless Remote Patient Monitoring
The US FDA granted 510(k) clearance to the Sleepiz One+, a contactless remote patient monitoring device for collecting biometric data and vital signs during sleep, enabling early detection of deterioration in chronic conditions.
2023-10
Medical Device Network
Sleepiz wins FDA clearance for device that measures vitals during sleep
Sleepiz's bedside device, utilizing radar technology, received FDA Class II 510(k) clearance for monitoring vital signs and screening for sleep apnea, expanding its use in remote monitoring.
2023-10
Xtalks
Sleepiz's At Home Sleep Monitoring Device Wins FDA Clearance
Zu00fcrich-based medtech startup Sleepiz AG received FDA Class II 510(k) clearance for its Sleepiz One+ device, allowing physicians to prescribe it for vital sign monitoring and sleep apnea screening.
2023-10
Clario
Clario and Sleepiz AG bring innovative sleep and respiratory data collection features to clinical trials
Clario partnered with Sleepiz AG to integrate contactless sleep and respiratory measurements into clinical trials, using unobtrusive radar technology for accurate and comfortable data collection.
2023-06
Startupticker.ch
Sleepiz closes Series A round at CHF 6,2 million
Sleepiz completed a second closing of its Series A financing round, raising an additional CHF 1.8 million, bringing the total to CHF 6.2 million, to launch its sleep apnea monitor in foreign markets.
2022-03
Venturelab Swiss
Sleepiz secures EUR 800,000 in funding and joins the largest U.S. telemedicine organization
Sleepiz received EUR 800,000 in funding as part of a European research project and joined the American Telehealth Association (ATA) to expand its presence in the U.S. market.
2022-10
Silicon Canals
Swiss startup Sleepiz secures u20ac4M to help patients suffering from chronic respiratory diseases; here's how
Sleepiz, an ETH spin-off, raised u20ac4 million in a Series A round to advance its contactless device for monitoring heart contractions, breathing patterns, and body motions with medical-grade accuracy.
2021-08
Startupticker.ch
Sleepiz AG secures USD 1 million
Sleepiz AG received $500k funding from the EU's HORIZON 2020 EUROSTAR grant, totaling $1M for research with Acconeer and University of Gothenburg, to co-develop a customized radar chip for next-generation contactless monitoring.
2021-05

Frequently Asked Questions

Sleepiz's core product is the Sleepiz One+, a contactless bedside device that uses radar technology to measure vital signs like heart rate, respiration rate, and body motion during sleep. For sleep apnea diagnosis, the device screens patients in their natural sleep environment, providing data that can be evaluated by experts. For chronic respiratory disease monitoring, it offers continuous, remote vital sign tracking to assist in early detection of deterioration and disease progression.
Sleepiz One+ utilizes wireless millimeter wave technology, digital signal processing, and AI-driven sleep analytics to measure vital signs with medical-grade accuracy. It has been clinically validated against gold-standard polysomnography for sleep parameters, respiration rate, and heart rate, showing high accuracy. The device holds FDA 510(k) clearance in the US and CE IIa certification in the European Union, affirming its compliance as a medical device.
For healthcare providers, Sleepiz's RPM solution offers continuous, objective vital sign data, enabling early detection of patient deterioration and informed decision-making, while potentially reducing hospitalizations. Patients benefit from comfortable, unobtrusive monitoring in their own homes, eliminating the need for wearables and reducing the burden of in-clinic visits.
Sleepiz partners with healthcare research technology companies like Clario to integrate innovative sleep and respiratory data collection into clinical trial workflows. This provides novel, patient-centric, and unobtrusive data endpoints, offering continuous, real-world data from home settings with high participant compliance.
Sleepiz prioritizes data protection and information privacy, holding ISO 27001, ISO 27701, and HIPAA certifications. They ensure that patient data is protected to the highest standards, using secure cloud technology and storing information in Swiss data centers, without using cameras or microphones in their devices.
While specific pricing details are not publicly disclosed, Sleepiz's revenue model is primarily based on the sale of its Sleepiz One+ product to healthcare providers, researchers, and clinical trial participants, with transactions structured as direct sales to hospitals and clinics, and potential subscription models for ongoing data services. Physicians in the U.S. can also reimburse the use of the device using CPT codes for remote patient monitoring. Sleepiz offers support for its medical devices and ensures data analysis and reporting for healthcare professionals.
Sleepiz has formed strategic partnerships with various organizations, including Clario for clinical trial data collection, AIIMS Patna for remote COVID-19 patient monitoring, and DrKure Technologies for remote monitoring services in India. They also collaborate with leading clinics in Switzerland and Europe and are part of European research projects focused on chronic respiratory disorder prediction and management.

Investors

Who's funded Sleepiz.

Related Companies

QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]

Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.